Answers are grounded in this paper and cite their sources.
Introduction: Anal fissure is the most common and distressful condition of the anal canal. It generally arises due to local trauma and hypertonicity of the anal sphincter. Many Unani physicians have mentioned it as shigafe miq’ad . Anal fissures are mainly caused by Sue mizaj har yabis of miq’ad and the passing of dry and hard stool. Many mufrad and murakkab formulations are mentioned in classical literature, but their efficacy has not been evaluated yet. Many allopathic conservative treatments are also available, but some of them contain certain side effects and are also very expensive. In this backdrop, this prospective, randomized study was designed to manage the anal fissures through topical application of Unani formulations viz Zaroore Aelwa and Zaroore Anzaroot with the main objective to find a convenient, nonoperative, painless, safe, affordable, efficient remedy in comparison to diltiazem (DTZ) 2% gel. Materials and Methods: Patients with acute or chronic fissures were enrolled in the study. A total of 90 patients were randomized into three groups. Group A (DTZ 2% gel users), Group B ( Zaroore Aelwa users), and Group C ( Zaroore Anzaroot users). Patients were followed up for 28 days and assessed for subjective (pain, bleeding, and itching) and objective (tenderness, sphincter spasm, and healing) parameters. Results: The study concluded that the test drugs ( Zaroore Aelwa and Zaroore Anzaroot ) are as effective as the control drug (DTZ 2% gel) in anal fissure. On assessment, at 4 weeks, there was significant relief in subjective parameters (pain, bleeding, and itching, with a P < 0.001) and objective parameters (tenderness, sphincter spasm, and healing, with a P < 0.001) in both groups. Conclusion: Our study suggests that Zaroore Aelwa and Zaroore Anzaroot are as effective as DTZ 2% gel and Zaroore Aelwa can be considered better in terms of being cost-effective, containing a single mufrad drug (i.e. Aelwa ), easily available, easy to prepare, and with lesser recurrence rate (3.3%) in comparison with Zaroore Anzaroot (6.7%) and hence can be used as an alternative in the treatment of fissure in ano.
No takes yet. Share an insight, caveat, or question.
Ansari et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: